Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southern Premier Owners Group (SPOG) was a prominent network of clinical research sites based in the Southeastern United States, specializing in Phase I-IV clinical trials. The organization operated as a consortium of high-performing, multi-specialty research centers with a strong focus on therapeutic areas such as oncology, cardiology, and metabolic diseases. In July 2022, SPOG was acquired by Velocity Clinical Research, the world’s largest integrated site organization. This acquisition integrated SPOG's regional expertise and patient access into Velocity's global network, facilitating more efficient clinical trial execution for pharmaceutical and biotech sponsors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southern Premier Owners Group.